Cronos Group Inc.
CRON- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001656472
No open-market purchases or sales by Cronos Group Inc. insiders were filed in the last 90 days; 194 institutions reported holding it in 13F filings for Q2 2026, worth $133.7M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Cronos Group Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 181 | 2 | 153 | −26 |
| Shares | 38.1M | 5.53M | 26.4M | −6.16M (−18.9%) |
| Value | $72.9M | $10.7M | $52.1M | −$10.1M (−16.2%) |
2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Cronos Group Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 37,857 | $74.6K | 0.00% |
| GTS Securities LLC | 29,155 | $57.4K | 0.00% |
| Flow Traders U.S. LLC | 11,562 | $23.0K | 0.00% |
| Cresset Asset Management, LLC | 10,765 | $21.2K | 0.00% |
| Fiduciary Alliance LLC | 3,660 | $7.21K | 0.00% |
| Rhumbline Advisers | 785 | $1.55K | 0.00% |
| ORG Partners LLC | 622 | $1.00K | 0.00% |
| Archer Investment Corp | 108 | $213 | 0.00% |
| Sittner & Nelson, LLC | 2 | $4 | 0.00% |
Sold out (35)
Institutions that held Cronos Group Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (2)
Institutions that held Cronos Group Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 5,528,091 | $10.7M |
| Householder Group Estate & Retirement Specialist, LLC | 43 | $0 |